No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Packaged Foods
AGV Products Corporation engages in the manufacturing, processing, and sale of beverages and canned goods in Taiwan and Mainland China. The company offers beverages, instant powders, fruit juices, dairy products, refrigerated series, desserts, traditional food, conditioning, oil products, and health products. It is also involved in the commissioning of construction companies to build residential and commercial buildings for leasing and sale. The company was founded in 1971 and is based in Chiayi Hsien, Taiwan.
www.agv.com.twNo one on the platform currently holds 1217.TW.
No tracked institution reports a position in 1217.TW as of their last filing.
No one on the platform has traded 1217.TW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 0.5% | 1.8% | 2.3% | — | — | — |
| Rev. Growth % | -1.6% | 1.8% | ||||
| Profit Margin % | 4.1% | 4.8% | 3.7% | |||
| Free Cash Flow Margin % | -1.4% | 3.2% | 3.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $4.4B | +0.0% | $0.11 | $0.11–$0.11 | — | 1 |
| 2027 | $4.7B | +5.1% | $0.27 | $0.27–$0.27 | — | 1 |
| 2028 | $4.9B | +4.1% | $0.30 | $0.30–$0.30 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.10 | $0.31 | +210.0% |
| 2026-05-08 | $0.10 | $-0.13 | -230.0% |
| 2026-03-10 | $0.10 | $0.11 | +10.0% |
| 2025-11-06 | $0.05 | $0.36 | +620.0% |
| 2025-08-11 | $0.10 | $0.14 | +40.0% |
| 2025-05-09 | $0.10 | $-0.19 | -290.0% |
| 2025-03-11 | $-0.05 | $-0.04 | +10.6% |
| 2024-11-08 | $-0.05 | $0.23 | +560.0% |
| -0.20% |
| $6.0B |
| — |
| 1256.TWSunjuice Holdings Co., Ltd. | $170.50 | -0.29% | $6.1B | — |
| 1271.TWOSunWay Biotech Co., Ltd. | $59.40 | -0.17% | $3.6B | — |
Source: Financial Modeling Prep · peers by sector/industry